Concepedia

Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

Rafael Molina, Xavier Filella, Josep M. Aug eacute, Rafael Fuentes, Isabel Bover, Juli Rifà, Vı́ctor Moreno, E Canals, Nuria Vi ntilde olas, Arian Benavides Márquez,

Tumor Biology · 2003 · 272 citations · 17 references

DOI

References

17

An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

Charles G. Moertel · JAMA · 1993 · 440 citations

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Journal of Clinical Oncology · 1996 · 430 citations

, , +13

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

Jean-Louis Pujol, Jean‐Christophe Grenier, J.-P. Daurès et al. · Lung Cancer · 1993 · 320 citations

, , +7

The international system for staging lung cancer

Clifton F. Mountain · Seminars in Surgical Oncology · 2000 · 216 citations

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Stephen L. Graziano, Rummana Mazid, Nancy Newman et al. · Journal of Clinical Oncology · 1989 · 189 citations

, , +15